4//SEC Filing
ANI PHARMACEUTICALS INC 4
Accession 0001144204-15-016478
$ANIPCIK 0001023024operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:36 PM ET
Size
10.0 KB
Accession
0001144204-15-016478
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2015-03-12$63.00/sh−300,000$18,900,000→ 2,350,559 total
Brown Robert E. JR
Director10% Owner
Transactions
- Sale
Common Stock
2015-03-12$63.00/sh−300,000$18,900,000→ 2,350,559 total
MERIDIAN VENTURE PARTNERS II LP
10% Owner
Transactions
- Sale
Common Stock
2015-03-12$63.00/sh−300,000$18,900,000→ 2,350,559 total
Meridian Venture Partners II, Co.
10% Owner
Transactions
- Sale
Common Stock
2015-03-12$63.00/sh−300,000$18,900,000→ 2,350,559 total
Footnotes (1)
- [F1]Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001023024
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:36 PM ET
- Size
- 10.0 KB